Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal

BACKGROUND: Four nonvitamin K antagonist oral anticoagulants (NOACs) are approved for the prevention of stroke in patients with nonvalvular atrial fibrillation and for the treatment of venous thromboembolism. These include the direct thrombin inhibitor dabigatran and the direct factor Xa inhibitors...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Crit Care
Autors principals: Brown, Karen S., Zahir, Hamim, Grosso, Michael A., Lanz, Hans J., Mercuri, Michele F., Levy, Jerrold H.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5034528/
https://ncbi.nlm.nih.gov/pubmed/27659071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-016-1422-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars